0001104659-22-127084.txt : 20221214
0001104659-22-127084.hdr.sgml : 20221214
20221214201157
ACCESSION NUMBER: 0001104659-22-127084
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221212
FILED AS OF DATE: 20221214
DATE AS OF CHANGE: 20221214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dudley Robert Michael
CENTRAL INDEX KEY: 0001854161
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40363
FILM NUMBER: 221463464
MAIL ADDRESS:
STREET 1: C/O TRANSCODE THERAPEUTICS
STREET 2: 6 LIBERTY SQUARE #2382
CITY: BOSTON
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Transcode Therapeutics, Inc.
CENTRAL INDEX KEY: 0001829635
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811065054
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6 LIBERTY SQUARE
STREET 2: #2382
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-301-6857
MAIL ADDRESS:
STREET 1: 6 LIBERTY SQUARE
STREET 2: #2382
CITY: BOSTON
STATE: MA
ZIP: 02109
4
1
tm2232745-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-12-12
0
0001829635
Transcode Therapeutics, Inc.
RNAZ
0001854161
Dudley Robert Michael
C/O TRANSCODE THERAPEUTICS, INC.
6 LIBERTY SQUARE, #2382
BOSTON
MA
02109
1
1
1
0
Chief Executive Officer
Stock Option (Right to Buy)
0.51
2022-12-12
4
A
0
135000
0
A
2032-12-11
Common Stock
135000
135000
D
Thirty-three percent (33%) of the Stock Options shall vest and become exercisable on the one year anniversary of Vesting Commencement Date (December 1, 2022). Thereafter, the remaining sixty-seven percent (67%) of the Stock Options shall vest and become exercisable in 24 equal monthly installments on the last day of each such month following the first anniversary of the Vesting Commencement Date, provided the Reporting Person continues to have a Service Relationship with the Company on each vesting date.
/s/ Thomas A. Fitzgerald, as Attorney-in-Fact
2022-12-14